Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Orchard Therapeutics plc (ORTX)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-05-23Mar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Jun-30-22
   10-Q8-K10-Q8-K10-K8-K10-Q10-Q
Revenues   [+]7.37.31.21.27.07.05.84.4
            Revenue growth  67.4%67.4%-77.6%-77.6%1346.4%1346.4%384.6% 
Cost of goods sold  2.22.20.40.42.42.41.61.1
Gross profit  5.15.10.90.94.64.64.13.2
            Gross margin  70.1%70.1%70.3%70.3%65.2%65.2%71.5%74.3%
Selling, general and administrative   [+]27.711.027.111.136.110.629.635.7
Research and development          
Other operating expenses  -20.616.7-13.816.0-45.225.546.437.4
EBITDA   [+]-1.3 -11.8 14.3 -71.2-69.2
            EBITDA margin  -18.4%-308.5%-953.8%-2122.7%204.5%-452.2%-1232.1%-1583.4%
Depreciation  0.6 0.5 0.7 0.40.6
EBITA  -1.9-22.6-12.3-26.313.6-31.6-71.5-69.7
            EBITA margin  -26.0%-308.5%-997.7%-2122.7%194.2%-452.2%-1238.2%-1596.2%
Amortization of intangibles  0.1 0.1   0.30.1
EBIT   [+]-2.0-22.6-12.4-26.313.6-31.6-71.8-69.8
            EBIT margin  -27.4%-308.5%-1005.8%-2122.7%194.2%-452.2%-1243.4%-1598.5%
Interest expense, net   [+]-1.4 -1.0 -0.90.9-0.4-0.2
Other income (expense), net  -10.710.3-5.18.8-22.523.523.619.1
Pre-tax income  -12.3-12.3-17.4-17.4-9.0-9.0-48.6-51.1
Income taxes  0.00.00.00.0-1.1-1.1-1.1-0.2
            Tax rate   0.0%0.1%0.1%12.5%12.5%2.2%0.4%
Net income  -12.30.0-17.4-17.4-7.9-7.9-47.6-50.9
            Net margin  -168.3%0.0%-1407.6%-1407.6%-112.8%-112.8%-823.4%-1165.7%
   
Basic EPS   [+]($0.07) ($0.12)($0.12)($0.06)($0.06)($0.37)($0.40)
Diluted EPS   [+]($0.07) ($0.12)($0.12)($0.06)($0.06)($0.37)($0.40)
   
Shares outstanding (basic)   [+]189.3 141.8141.8128.0128.2128.1127.9
Shares outstanding (diluted)   [+]189.3 141.8141.8128.0128.2128.1127.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy